{"id":"NCT01978093","sponsor":"GlaxoSmithKline","briefTitle":"Immunogenicity, Safety and Reactogenicity Study of GlaxoSmithKline (GSK) Biologicals' Hib-MenCY-TT (MenHibrix®) Vaccine Compared to Merck & Co, Inc. PedvaxHIB Vaccine in Healthy Infants and Toddlers 12 to 15 Months of Age","officialTitle":"Immunogenicity, Safety and Reactogenicity of GSK Biologicals' Hib-MenCY-TT (MenHibrix®) Vaccine 792014 Compared to Merck & Co, Inc. Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate) Vaccine in Healthy Infants and Toddlers","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2014-02-01","primaryCompletion":"2016-03-18","completion":"2016-03-18","firstPosted":"2013-11-07","resultsPosted":"2018-06-26","lastUpdate":"2018-09-14"},"enrollment":600,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"PREVENTION"},"conditions":["Neisseria Meningitidis","Haemophilus Influenzae Type b"],"interventions":[{"type":"BIOLOGICAL","name":"Hib-MenCY-TT (MenHibrix®)","otherNames":[]},{"type":"BIOLOGICAL","name":"Pediarix®","otherNames":[]},{"type":"BIOLOGICAL","name":"Rotarix®","otherNames":[]},{"type":"BIOLOGICAL","name":"Prevnar 13®","otherNames":[]},{"type":"BIOLOGICAL","name":"PedvaxHIB®","otherNames":[]},{"type":"BIOLOGICAL","name":"Havrix®","otherNames":[]}],"arms":[{"label":"HibCY Group","type":"EXPERIMENTAL"},{"label":"PedHIB Group","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this study is to evaluate the safety, reactogenicity and immunogenicity of GSK Biologicals' Hib-MenCY-TT (MenHibrix®) vaccine co-administered with Rotarix, Prevnar 13 and Havrix as compared to PedvaxHIB co-administered with Rotarix, Prevnar 13 and Havrix in infants and toddlers.","primaryOutcome":{"measure":"Percentage of Subjects With Anti-Polyribosylribitol Phosphate (Anti-PRP) Antibody Concentrations Greater Than or Equal to (≥) 1.0 µg/mL","timeFrame":"1 month after the fourth dose for HibCY Group and 1 month after third dose for PedHIB Group [Month (M) 11-14]","effectByArm":[{"arm":"HibCY Group","deltaMin":98.2,"sd":null},{"arm":"PedHIB Group","deltaMin":97.2,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":null}]},"eligibility":{"minAge":"6 Weeks","sex":"ALL","healthyVolunteers":true,"inclusionCount":6,"exclusionCount":13},"locations":{"siteCount":26,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":8,"n":297},"commonTop":["Irritability","Somnolence","Injection site pain","Injection site erythema","Decreased appetite"]}}